Asia · Regional markets · CNBC-TV18
Neuland Laboratories shares in focus after Q2 results see revenue drop and margin contraction
Neuland Laboratories' margins in the September quarter contracted to 24.1% from 30.2% in the year-ago period and from 34.7% in the prior quarter.
Read the full article on CNBC-TV18 Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)



